Clinical Trial Update: hCG Priming in Women With Diminished Ovarian Reserve [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating hCG priming in women with diminished ovarian reserve undergoing IVF and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diminished Ovarian Reserve
• Infertility

Drugs mentioned

• hCG (human chorionic gonadotropin)

Snippet

Sponsor: Kristine Loessl | Conditions: Infertility, Female, Ovarian Reserve | Phase 3 | Status: RECRUITING